Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


A Randomized, Placebo-controlled Trial of Psychedelic-assisted Psychotherapy With Single Dose Psilocybin for Frontline Clinicians Experiencing COVID-related Symptoms of Depression and Burnout


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05163496

Organisation Name: University of Washington

Overal Status: Recruiting

Start Date: March 3, 2022

Last Update: July 15, 2022

Lead Sponsor: University of Washington

Brief Summary: This study aims to investigate the effects of a single dose of psilocybin, delivered in the contextof pre- and post-dose psychotherapy, on symptoms of depression and burnout suffered by healthcare clinicians as a result of frontline work in the COVID pandemic.

Conditions:
  • Burnout, Caregiver
  • Burnout, Professional
  • COVID-19
  • Depression
  • Post Traumatic Stress Disorder
  • Moral Injury


Total execution time in seconds: 0.21694922447205